Wednesday, July 22, 2026

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

Coupang’s Testimony: How Will It Impact U.S.-Korea Trade Relations?

Coupang's interim CEO testifies before U.S. Congress amid trade tensions with South Korea, raising concerns about discrimination against U.S. firms.

U.S.-South Korea Talks Heat Up Over Military Funds

The Fourth Round of Consultations on the 12th U.S.-ROK Special Measures Agreement(SMA) will be held in Seoul from the 25th to the 27th.

Tag: transgender participation

No posts to display

Top News

- Our Sponsors Ad -

Follow us